In B*57:01-KC, culture supernatant IFN-γ and IL-1β protein levels were below the detection limit (15.6 pg/mL) with or without Abacavir exposure at 100 μM for 12 h. In 721.220.B*57:01 cultures treated with Abacavir at 60 µM 20 h before the assay, Abacavir had no apparent impact on HLA-B*57:01 maturation in either the presence or absence of tapasin. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Abacavir and cytokine detection in culture supernatant
Cell-based study · B*57:01-KC [1]
B*57:01-KC were exposed to Abacavir at 100 μM for 12 h. Culture supernatant protein levels of IFN-γ and IL-1β remained below the detection limit (15.6 pg/mL) with or without Abacavir exposure.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μM
- Exposure duration
- 12 h
- Method
- abacavir exposure
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Abacavir
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > HLA-B*57:01-expressing keratinocytes were immunologically activated by abacavir (S7)
Protein levels of IFN-γ and IL-1β in the culture supernatant: Protein levels of IFN-γ and IL-1β in the culture supernatant; comparator: without abacavir exposure — Results > HLA-B*57:01-expressing keratinocytes were immunologically activated by abacavir (S7)
Abacavir and HLA maturation
Cell-based study · 721.220.B*57:01 [2]
721.220.B*57:01 cells received Abacavir at 60 µM 20 h before the assay. Abacavir had no apparent impact on HLA-B*57:01 maturation in either the presence or absence of tapasin.
Literature-Reported Treatment Conditions
- Treatment concentration
- 60 µM
- Exposure duration
- 20 h before the start of the assay
- Method
- added to 2 × 107 cells in 50 ml culture medium
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Abacavir
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > MHC I Pulse-Chase Maturation Assay (S68, S69, S70, S71, S73); Figure 4 legend (S243, S247)
Maturation [acquisition of resistance to digestion with endoglycosidase-H (Endo-H)] of HLA-B*57:01 molecules: Maturation [acquisition of resistance to digestion with endoglycosidase-H (Endo-H)] of HLA-B*57:01 molecules; comparator: in the absence of abacavir in otherwise identical conditions — Figure 4 legend (S243, S247)